In 2016, Terri was diagnosed with neuropathic pain, which forced her to quit her job and made simple tasks like sitting, walking, and playing with her dogs unbearable.
Neuropathic pain is very complex and can result in dysfunctional pain signals being processed in the brain.
Terri participated in a focused ultrasound clinical trial* at the University of Maryland in fall 2020 and says the treatment “was like a miracle.”
The Foundation partnered with the Cancer Research Institute (CRI) to host a virtual workshop to discuss recent advances in focused ultrasound for cancer immunotherapy.
Video recordings of the presentations are now available.
Speaker details are now available for the next two workshops in the “Detecting, Mapping, and Quantifying Bubble Activity in Therapeutic Ultrasound” virtual series.
Registrants can watch previous workshop recordings in the online portal.
Join us every Friday until October 29 at 10:00 am Eastern.
Three new innovation laboratories are focused on bringing together the worlds of ultrasound and spinal cord injury.
The sites are called HEPIUS (Holistic Electrical, ultrasonic and Physiological Interventions Unburdening those with Spinal cord injury) after the Greek god of medicine and healing.
A group of researchers analyzed MRI, histology, and harmonic dose data to determine that the use of microbubbles and focused ultrasound was safe for opening the blood-brain barrier (BBB) in patients with infiltrating gliomas.
Data from the Phase 0 trial showed a significant, 2.2-fold increase of fluorescein accumulation in tumor tissues that were treated with microbubbles and focused ultrasound.
Muna Aryal, PhD, received a 2021 Healthy Longevity Catalyst Award for her project using focused ultrasound to enhance antibody delivery for brain imaging and therapy.
